FDA 483 - Amsino Healthcare (USA) Inc - September 20, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Amsino Healthcare (USA) Inc. in Vernon Hills, IL, was cited for multiple deficiencies during an FDA inspection from September 7-20, 2021. Key issues include inadequate process validation for smoke studies, poorly established and documented corrective and preventive actions, and a failure to appoint a permanent Quality Director. The firm also had issues with equipment cleaning, thoroughness of investigations into discrepancies and batch failures, and procedures for preventing microbiological contamination of sterile drug products.
ID · 80190cec-aa05-4bcc-9a5e-ccef817381aa